Dr. Reddy's Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.05.19	Dr. Reddy's Laboratories Q4 Profit Rises (RTTNews)
27.03.19	Dr. Reddy's Labs Launches Tadalafil Tablets, Generic Version Of Cialis, In U.S. (RTTNews)
19.02.19	New Drugs Approved In January (RTTNews)
04.02.19	Indivior Signs Deal With Alvogen; To Sell Stake In China For Up To $122.5 Mln (RTTNews)
28.01.19	Dr. Reddy's Labs: FDA Approves TOSYMRA Nasal Spray For Migraine - Quick Facts (RTTNews)
24.01.19	Dr. Reddy's Labs Launches Propofol Injectable Emulsion, USP In U.S. (RTTNews)
27.12.18	Dr. Reddy's Labs Unveils Renvela Generic Sevelamer Carbonate In U.S (RTTNews)
24.12.18	Dr. Reddy's Launches Aspirin And Extended-Release Dipyridamole Capsules In U.S. (RTTNews)
11.12.18	Dr. Reddy's Launches OTC Equivalent Of Prilosec - Quick Facts (RTTNews)
28.11.18	Dr. Reddy's Launches Chlorthalidone Tablets, USP In U.S. Market (RTTNews)
21.11.18	Indivior: CAFC Vacates Preliminary Injunction Granted Against Dr. Reddy's (RTTNews)
31.10.18	Dr. Reddy's Launches Atomoxetine Capsules, Generic Version Of Strattera, In U.S. (RTTNews)
28.10.18	Gericht ebnet Weg für Generikum von Johnson & Johnsons "Zytiga" (Dow Jones)
15.10.18	Dr. Reddy's: Aspirin And Extended-Release Dipyridamole Capsules Approved In US (RTTNews)
15.10.18	Dr. Reddy's To Sell API Manufacturing Business Unit In Hyderabad To Therapiva JV (RTTNews)
01.10.18	Dr. Reddy's Launches Imatinib Mesylate Tablets In U.S. - Quick Facts (RTTNews)
01.10.18	Dr. Reddy's Laboratories Regains Worldwide Rights To DFA-02 - Quick Facts (RTTNews)
12.09.18	Dr. Reddy's Labs Launches Neostigmine Methylsulfate Injection, USP In U.S. (RTTNews)
20.07.18	Dr. Reddy's Launches Generic Version Of Nexium 24HR Capsules - Quick Facts (RTTNews)
20.07.18	Indivior Finance S.ar.l. -- Moody's confirms Indivior's B3 Corporate Family Rating; revises outlook to negative (Moodys)
15.07.18	Dr Reddy's To Appeal U.S. Court's Preliminary Injunction On Generic Suboxone (RTTNews)
11.07.18	Indivior Removes FY18 View As It Now Sees Results Below Previous Expectations (RTTNews)
19.06.18	Dr. Reddy's Launches Generic Version Of HQ Specialty Pharma's Levetiracetam (RTTNews)
18.06.18	Why These Stocks Posted Gains? (RTTNews)
17.06.18	Dr. Reddy's Defends Right To Launch Buprenorphine,Naloxone Sublingual Film In US (RTTNews)
15.06.18	Indivior Finance S.ar.l. -- Moody's places Indivior's ratings under review for downgrade (Moodys)
15.06.18	Dr. Reddy's Laboratories announces USFDA final approval and launch of Buprenorphine and Naloxone Sublingual Film in the U.S. Market (PR Newswire)
15.06.18	FDA Okays First Generic Versions Of Suboxone Sublingual Film (RTTNews)
11.04.18	Shook, Hardy & Bacon Deepens Regulatory & Compliance Strengths with Addition of Former FDA Attorney (PR Newswire)
26.03.18	Dr. Reddy's Labs Launches Palonosetron Hydrochloride Injection In U.S. (RTTNews)
26.12.17	Dr. Reddy's Labs Launches Melphalan Hydrochloride For Injection In U.S. (RTTNews)
19.12.17	Dr. Reddy's To Pay $5 Mln In Settlement With US Government In Packaging Case (RTTNews)
01.12.17	Dr. Reddy's Announces Approval Of Impoyz Cream, 0.025% First-Cycle NDA Approval (RTTNews)
14.11.17	Dr. Reddy's Launches Therapeutic Equivalent Generic Version Of Clolar Injection (RTTNews)
24.10.17	Lifshitz & Miller LLP Announces Investigation of Antares Pharma, Inc., CenturyLink, Inc., CytRx Corporation, Dentsply Sirona, Inc., Dr. Reddy's Laboratories Limited, J.Jill, Inc., and Navient... (PR Newswire)
18.10.17	EQUITY ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited (PR Newswire)
23.09.17	DR. REDDY'S SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd. - (RDY) (PR Newswire)
16.09.17	DR. REDDY'S SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit... (PR Newswire)
06.09.17	IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm (PR Newswire)
05.09.17	IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm (PR Newswire)
01.09.17	RBP Global Holdings Ltd -- Moody's: Patent ruling is credit negative for Indivior (Moodys)
29.08.17	Scott+Scott, Attorneys at Law, LLP Announces Filing of Securities Class Action Against Dr. Reddy's Laboratories Limited (RDY) (PR Newswire)
28.08.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Dr. Reddy's Laboratories Ltd. (RDY) & Lead Plaintiff Deadline: October 24, 2017 (PR Newswire)
28.08.17	Dr. Reddy's Labs Launches Cefixime For Oral Suspension, USP In US (RTTNews)
22.08.17	Dr. Reddy's Labs Announces Out-Licensing Of DFD-06 To Encore Dermatology (RTTNews)
12.08.17	Dr. Reddy's (RDY) Alert: J&W Investigates Dr. Reddy's Laboratories Ltd.; Has Your Dr. Reddy's Investment Declined in Value? (PR Newswire)
10.08.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dr. Reddy's Laboratories Ltd. (RDY) (PR Newswire)
10.08.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Ltd. - RDY (PR Newswire)
06.06.17	Dr. Reddy's Launches Angiomax' Generic Bivalirudin For Injection In U.S. (RTTNews)
17.05.17	Dr. Reddy's To Launch Generic Version Of Doxil - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

06.11.24		Gewinne in New York: NASDAQ Composite zum Ende des Mittwochshandels mit positivem Vorzeichen
06.11.24		Aufschläge in New York: NASDAQ Composite verbucht am Mittwochnachmittag Gewinne
06.11.24		Mittwochshandel in New York: NASDAQ Composite liegt mittags im Plus
21.10.24		Minuszeichen in New York: NASDAQ Composite am Montagmittag leichter
15.10.24		Schwacher Handel in New York: NASDAQ Composite legt schlussendlich den Rückwärtsgang ein
15.10.24		Freundlicher Handel in New York: NASDAQ Composite verbucht zum Start des Dienstagshandels Zuschläge
04.09.24		Handel in New York: NASDAQ Composite startet in der Verlustzone
14.08.24		NASDAQ Composite aktuell: NASDAQ Composite bewegt sich mittags im Plus

06.11.24

Gewinne in New York: NASDAQ Composite zum Ende des Mittwochshandels mit positivem Vorzeichen

06.11.24

Aufschläge in New York: NASDAQ Composite verbucht am Mittwochnachmittag Gewinne

06.11.24

Mittwochshandel in New York: NASDAQ Composite liegt mittags im Plus

21.10.24

Minuszeichen in New York: NASDAQ Composite am Montagmittag leichter

15.10.24

Schwacher Handel in New York: NASDAQ Composite legt schlussendlich den Rückwärtsgang ein

15.10.24

Freundlicher Handel in New York: NASDAQ Composite verbucht zum Start des Dienstagshandels Zuschläge